New hope for aggressive lung cancer: drug cocktail shows promise
Disease control
Recruiting now
This study tests a new combination of drugs (chidamide, a PD-L1 inhibitor, and two chemotherapy drugs) as a first treatment for people with extensive-stage small-cell lung cancer, a fast-growing cancer that has spread. About 36 participants will receive the combo for 4 cycles, th…
Phase: PHASE2 • Sponsor: China Medical University, China • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC